These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6237806)
1. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy. Welsch CW; DeHoog JV; Moon RC Carcinogenesis; 1984 Oct; 5(10):1301-4. PubMed ID: 6237806 [TBL] [Abstract][Full Text] [Related]
2. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors. Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide. Welsch CW; DeHoog JV; Moon RC Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778). Bollag W; Hartmann HR Eur J Cancer Clin Oncol; 1987 Feb; 23(2):131-5. PubMed ID: 2965015 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate. Moon RC; Grubbs CJ; Sporn MB Cancer Res; 1976 Jul; 36(7 PT 2):2626-30. PubMed ID: 819130 [TBL] [Abstract][Full Text] [Related]
6. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843 [TBL] [Abstract][Full Text] [Related]
7. Influence of dietary retinyl acetate on normal rat mammary gland development and on the enhancement of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by high levels of dietary fat. Aylsworth CF; Cullum ME; Zile MH; Welsch CW J Natl Cancer Inst; 1986 Feb; 76(2):339-45. PubMed ID: 3080638 [TBL] [Abstract][Full Text] [Related]
9. Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis. Moon RC; Constantinou AI Breast Cancer Res Treat; 1997; 46(2-3):181-9. PubMed ID: 9478273 [TBL] [Abstract][Full Text] [Related]
10. Retinoids as chemopreventive agents for breast cancer. Moon RC; Mehta RG; Detrisac CJ Cancer Detect Prev; 1992; 16(1):73-9. PubMed ID: 1551141 [TBL] [Abstract][Full Text] [Related]
11. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Moon RC; Thompson HJ; Becci PJ; Grubbs CJ; Gander RJ; Newton DL; Smith JM; Phillips SL; Henderson WR; Mullen LT; Brown CC; Sporn MB Cancer Res; 1979 Apr; 39(4):1339-46. PubMed ID: 421218 [TBL] [Abstract][Full Text] [Related]
12. Effect of retinyl acetate on the occurrence of ovarian hormone-responsive and -nonresponsive mammary cancers in the rat. Thompson HJ; Meeker LD; Tagliaferro AR; Becci PJ Cancer Res; 1982 Mar; 42(3):903-5. PubMed ID: 6800647 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2). McCormick DL; Becci PJ; Moon RC Carcinogenesis; 1982; 3(12):1473-6. PubMed ID: 6217919 [TBL] [Abstract][Full Text] [Related]
14. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636 [TBL] [Abstract][Full Text] [Related]
15. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model. RodrÃguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen. Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970 [TBL] [Abstract][Full Text] [Related]
17. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth. Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682 [TBL] [Abstract][Full Text] [Related]
19. Effect of N-(4-hydroxyphenyl) retinamide on food intake, growth, and mammary gland development in rats. Radcliffe JD; Moon RC Proc Soc Exp Biol Med; 1983 Nov; 174(2):270-5. PubMed ID: 6227008 [TBL] [Abstract][Full Text] [Related]
20. Influence of hormones on N-(4-hydroxyphenyl) retinamide inhibition of 7,12-dimethylbenz[alpha]anthracene transformation of mammary cells in organ culture. Chatterjee M; Banerjee MR Cancer Lett; 1982 Sep; 16(3):239-45. PubMed ID: 6217889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]